1. Home
  2. LQDA vs CARG Comparison

LQDA vs CARG Comparison

Compare LQDA & CARG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$37.80

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Logo CarGurus Inc.

CARG

CarGurus Inc.

HOLD

Current Price

$37.08

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
CARG
Founded
2004
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.3B
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
LQDA
CARG
Price
$37.80
$37.08
Analyst Decision
Strong Buy
Buy
Analyst Count
11
11
Target Price
$41.00
$38.32
AVG Volume (30 Days)
1.1M
928.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
51.81
675.00
EPS
N/A
1.55
Revenue
$158,320,000.00
$316,861,000.00
Revenue This Year
$278.87
$13.89
Revenue Next Year
$57.13
$8.91
P/E Ratio
N/A
$23.81
Revenue Growth
1031.18
59.92
52 Week Low
$11.85
$25.41
52 Week High
$46.67
$39.42

Technical Indicators

Market Signals
Indicator
LQDA
CARG
Relative Strength Index (RSI) 49.78 67.50
Support Level $31.75 $32.95
Resistance Level $39.19 $38.89
Average True Range (ATR) 2.12 1.21
MACD 0.09 0.17
Stochastic Oscillator 37.52 92.82

Price Performance

Historical Comparison
LQDA
CARG

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. The company provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

Share on Social Networks: